Testing effectiveness (Phase 2)Study completedNCT00686803
What this trial is testing
Safety Study of Subcutaneously Administered PL-3994 in Subjects With Controlled Hypertension
Who this might be right for
Hypertension
Palatin Technologies, Inc 21
Showing 20 of 0 results